A Multi‐Center Real‐World Study of Clinicopathologic Characteristics and Efficacy of the Malignant Mesothelioma in Chinese Population
Chinese population with MM present unique clinicopathologic characteristics and could benefit from the first-line immunotherapy and bevacizumab combined with chemotherapy. Gender, histologic subtype, and CK5/6 are prognosis factors for OS. BAP1 deletions correlate with OS benefit.
Authors
- Bin Ai (ORCID: https://orcid.org/0000-0001-7257-751X)
- Zhixin Bie (ORCID: https://orcid.org/0000-0002-7337-2409)
- Jia Zhong (ORCID: https://orcid.org/0000-0002-0464-3754)
- Hao-Lan Liu (ORCID: https://orcid.org/0000-0002-3705-6388)
- Jiangyong Yu (ORCID: https://orcid.org/0000-0002-3353-1460)
- Lan Chen (ORCID: https://orcid.org/0000-0002-9625-347X)
- Juanjuan Liu (ORCID: https://orcid.org/0000-0002-1062-4488)
- Junling Ma
- Zitong Zheng (ORCID: https://orcid.org/0009-0007-2458-4548)
- Xue Yang (ORCID: https://orcid.org/0000-0003-2768-1865)
- Can-Lan Sun
- Runting Kang
Institutions
- Binzhou Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Peking University Cancer Hospital (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/1759-7714.15533
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China